NPIL-Eli Lilly clinical drug trial gets nod from Holland

February 26th, 2008 - 1:52 pm ICT by admin  


Mumbai, Feb 26 (IANS) Nicholas Piramal Research and Development ltd (NRDL), which had recently signed a $100 million drug development and marketing agreement with US-based pharmaceutical major Eli Lilly, Tuesday announced the commencement of Phase I studies of an experimental drug for metabolic disorders. NRDL, the de-merged research entity of Nicholas Piramal India ltd (NPIL), stated in its official communiqu

Tags: , , , , , , , , , , , , , ,

Posted in Business |

Subscribe